Talc Pleurodesis Success Rate — SCE Palliative Medicine MCQ

Instant feedback + full explanation. One question, done properly.

HardRespiratory SymptomsTalc Pleurodesis Success RateSCE Palliative Medicine

A patient with tumour-related bronchial obstruction is selected for a corticosteroid trial. Which dexamethasone daily range matches hollow-viscus obstruction guidance?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Dexamethasone 6–16 mg/day

Explanation lettering: C = shown as B · B = shown as C

D is correct. Obstruction of bowel, bronchus or ureter uses 6–16 mg/day. The dose is titrated to clinical effect and withdrawn if ineffective.

Reference: Scottish Palliative Care Guidelines: dexamethasone: https://www.rightdecisions.scot.nhs.uk/scottish-palliative-care-guidelines/medicines-information/dexamethasone/